Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization

Vu C Dang1, Billy Chieng, Yael Azriel

  • 1Pain Management Research Institute and Kolling Institute and Brain and Mind Research Institute, The University of Sydney, Sydney, New South Wales 2006, Australia.

Insights

Opioid tolerance involves impaired μ-opioid receptor (MOR) resensitization. This study found that βarrestin-2 (βarr-2) and dynamin are not required for MOR resensitization in neurons, and chronic morphine disrupts this process.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Chronic morphine treatment leads to opioid tolerance, potentially due to reduced recovery of μ-opioid receptors (MORs) from desensitization.
  • βarrestin-2 (βarr-2)-dependent trafficking to endosomes and subsequent recycling is hypothesized to be crucial for MOR resensitization.

Purpose of the Study:

  • To investigate the role of βarrestin-2 (βarr-2) and dynamin in MOR resensitization within native neurons.
  • To determine if βarr-2/dynamin-dependent trafficking is essential for MOR resensitization in opioid-naive and morphine-treated mice.

Main Methods:

  • Whole-cell patch-clamp electrophysiology was employed in locus ceruleus (LC) neurons from wild-type and βarr-2 knock-out mice.
  • Experiments examined MOR resensitization following acute desensitization in both opioid-naive and chronically morphine-treated conditions.

Main Results:

  • MOR resensitization in LC neurons does not require βarr-2 or dynamin-dependent trafficking; in fact, disrupting these pathways accelerated resensitization.
  • Chronic morphine treatment impaired MOR resensitization in wild-type neurons but not in βarr-2 knock-out neurons.
  • Disrupting G-protein-coupled receptor kinase-2 (GRK2) or dynamin function reversed the impairment of MOR resensitization caused by chronic morphine.

Conclusions:

  • βarrestin-2/dynamin-dependent receptor regulation is not essential for MOR resensitization in LC neurons.
  • Chronic morphine alters GRK2-βarr-2-dynamin-dependent MOR trafficking, impairing receptor resensitization and contributing to opioid tolerance by reducing surface receptor levels.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...